Ramot manages all of the university's commercialization activities – filing patent applications and maintaining patents claiming intellectual property invented by researchers of Tel Aviv University and granting licenses to relevant industrial partners with respect to such intellectual property.

[3] Ramot identifies and engages with industrial partners to further develop discoveries and inventions created by Tel Aviv University’s researchers.

Ramot is active mainly in the fields of engineering, computer science, medicine, biotechnology, food-tech, materials and medical devices.

[5] Ramot has collaboration agreements with international companies such as Pfizer, Teva,[6] Bayer,[7] Samsung,[8] Google, Microsoft,[9] Merck,[10] Novartis,[11] GSK and more.

The Momentum Fund raised close to US 24 million dollars and invested in 28 technologies, of which 5 have led to the creation of the start-up companies QArt Medical, Unispectral, Trobix, Multivu and Silib, and 13 of which are in various stages of research and development.